相关实验视频
Updated: Jun 11, 2025

Intratracheal Administration of Dry Powder Formulation in Mice
Published on: July 25, 2020
吸入式干粉用于肺部mRNA输送
Akiva Gordon1,2, Bowen Li1,2,3,4,5, Jacob Witten1,2,6
1David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
使用喷雾冷干燥开发可吸入的mRNA干粉是一种安全有效的肺部输送方法. 这些稳定,强效的配方通过吸入使mRNA有效地分布到深肺.
科学领域:
- 生物技术是生物技术.
- 肺部药物输送 肺部药物输送
- 纳米医学是一种纳米医学.
背景情况:
- 使者RNA (mRNA) 疗法显示出希望,但在肺部传递方面面临挑战.
- 液态mRNA配方的直接内灌注在人类中引发了安全和分发方面的担忧.
- 吸入式配方是安全有效的mRNA输送到肺部的必要条件.
研究的目的:
- 开发稳定,可吸入的脂质纳米颗粒干粉配方,用于将mRNA输送到肺部.
- 为了评估这些干粉配方的气溶性质和肺mRNA输送效率.
- 评估开发的配方与各种电离性脂质的兼容性.
主要方法:
- 喷雾冷干燥被用来创建干粉脂质纳米粒子配方.
- 气溶性质的特征是通过测量平均质量空气动力直径 (MMAD) 和微粒分数 (FPF) 来进行.
- 在体内肺部mRNA输送被评估为不同的可电离脂基配方.
主要成果:
- 干粉配方表现出适合深肺输送的气溶性质 (MMAD 3-4微米,FPF ≈40%).
- 四种不同的基于可电离脂的配方已成功制备为可吸入的干粉.
- 所有评估的干粉配方在体内证明肺mRNA输送与液体配方相比.
结论:
- 喷雾冷干燥的脂质纳米颗粒干粉是可吸入mRNA治疗的有希望的平台.
- 开发的配方是强大的,生物活性,并与各种电离性脂质兼容.
- 这项工作为吸入mRNA干粉治疗肺部疾病的临床开发铺平了道路.
更多相关视频
04:59Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
相关概念视频
Inhaled Medications
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...